Insiders Updates
Monitoring BridgeBio Pharma Inc (BBIO) after recent insider movements
BridgeBio Pharma Inc’s filing revealed that its 10% Owner KKR Genetic Disorder L.P. unloaded Company’s shares for reported $149.35 million
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.